Results 11 to 20 of about 223,805 (315)

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer

open access: yesJournal for ImmunoTherapy of Cancer, 2021
Background Peritoneal carcinomatosis is a fatal clinical presentation of colon cancer, characterized by unresponsiveness to conventional anticancer therapies, including immune checkpoint inhibitors.
Jeong Hun Kim   +11 more
doaj   +2 more sources

Peritoneal carcinomatosis [PDF]

open access: yesWorld Journal of Gastroenterology, 2013
Several gastrointestinal and gynecological malignancies have the potential to disseminate and grow in the peritoneal cavity. The occurrence of peritoneal carcinomatosis (PC) has been shown to significantly decrease overall survival in patients with liver
Ansaloni L   +10 more
core   +6 more sources

Indocyanine green fluorescence-guided intraoperative detection of peritoneal carcinomatosis: systematic review

open access: yesBMC Surgery, 2020
Background To review the available clinical data about the value of Indocyanine Green (ICG) fluorescence imaging for intraoperative detection of peritoneal carcinomatosis.
Gian Luca Baiocchi   +5 more
doaj   +2 more sources

Preclinical evaluation of local prolonged release of paclitaxel from gelatin microspheres for the prevention of recurrence of peritoneal carcinomatosis in advanced ovarian cancer [PDF]

open access: yesScientific Reports, 2019
Patients with advanced ovarian cancer develop recurrence despite initial treatment response to standard treatment of surgery and intravenous/intraperitoneal (IP) chemotherapy, partly due to a limited peritoneal exposure time of chemotherapeutics ...
Ceelen, Wim   +7 more
core   +3 more sources

An Unusual Case of Peritoneal Carcinomatosis [PDF]

open access: yesCase Reports in Oncology, 2010
The peritoneal surface remains an important failure site for patients with gastrointestinal and gynecologic malignancies. In the past, oncologists regarded peritoneal carcinomatosis as an incurable component of an intra-abdominal malignancy.
Stijn Hillewaere   +2 more
doaj   +3 more sources

Diagnosis and treatment of peritoneal carcinomatosis - a comprehensive overview. [PDF]

open access: yesPol J Radiol, 2023
Peritoneal carcinomatosis, which is the most common malignant process of the peritoneal cavity, originates mostly from colorectal, gastric, and gynaecological malignancies.
Szadkowska MA   +2 more
europepmc   +2 more sources

Risk of Peritoneal Carcinomatosis After Risk-Reducing Salpingo-Oophorectomy: A Systematic Review and Individual Patient Data Meta-Analysis

open access: yesJournal of Clinical Oncology, 2022
PURPOSE After risk-reducing salpingo-oophorectomy (RRSO), BRCA1/2 pathogenic variant (PV) carriers have a residual risk to develop peritoneal carcinomatosis (PC). The etiology of PC is not yet clarified, but may be related to serous tubal intraepithelial
M. Steenbeek   +21 more
semanticscholar   +1 more source

Tuberculous peritonitis masquerading as carcinomatosis [PDF]

open access: yesClinical Case Reports, 2020
AbstractTuberculous peritonitis may debut with unspecific symptoms that can pose a diagnostic challenge for clinicians. We present a patient with tuberculous peritonitis masquerading as carcinomatosis. High clinical suspicion, appropriate identification of bacterial isolates of the Mycobacterium tuberculosis complex, and susceptibility testing are ...
Gabriel Motoa, Salvador Alvarez
openaire   +3 more sources

Validation of 18F-FDG PET/MRI and diffusion-weighted MRI for estimating the extent of peritoneal carcinomatosis in ovarian and endometrial cancer -a pilot study

open access: yesCancer Imaging, 2021
Background The extent of peritoneal carcinomatosis is difficult to estimate preoperatively, but a valid measure would be important in identifying operable patients .
B. Jónsdóttir   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy